Skip to main content
Medinice S.A. logo

Medinice S.A. — Investor Relations & Filings

Ticker · ICE ISIN · PLMDNCE00016 LEI · 259400LGO9UDV1Y18Z11 WAR Manufacturing
Open in API
Filings indexed 761 across all filing types
Latest filing 2025-03-07 Regulatory Filings
Country PL Poland
Listing WAR ICE

About Medinice S.A.

https://www.medinice.pl/?lang=2

Medinice S.A. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions in the fields of cardiology and cardiac surgery. The company's mission is to create patient-focused technologies that improve the quality of life for individuals with cardiac diseases. Its portfolio consists of advanced medical devices, including Class III devices, which undergo a full research, development, and clinical trial process before market introduction. Key projects include CoolCryo, a cryoablation system; AtriClamp, for left atrial appendage closure; and PacePress, a specialized compression band used after cardiac device implantation procedures.

Recent filings

Filing Released Lang Actions
Uzyskanie dofinansowania na projekt "AtriClamp"
Regulatory Filings Classification · 99% confidence The document is a short announcement (867 characters) from the Management Board of MEDINICE S.A. informing about receiving notification from the Mazowieckie Voivodeship Board regarding the approval of funding for a project ('AtriClamp') under the European Funds for Mazovia 2021-2027 Program. This concerns receiving funding/financing for a project, which aligns best with the Capital/Financing Update category (CAP). It is not a full report, an earnings release, or a standard regulatory filing like 10-K or IR, but a specific announcement about securing financial support/grants.
2025-03-07 Polish
Uzyskanie certyfikatu CE MDR na bazie komparatora dla urządzenia PacePress - Content (EN)
Regulatory Filings Classification · 100% confidence The document text announces that MEDINICE S.A. has successfully completed the CE MDR comparison certification process for its medical device, PacePress Fast. This is a specific operational and regulatory achievement announcement, not a standard financial report (like 10-K or IR), a management change (MANG), or a shareholder vote result (DVA). It relates to regulatory compliance and market access, which is a type of significant corporate event. Since there is no specific category for 'Regulatory Approval/Certification', and it is a formal announcement of a regulatory milestone that impacts future performance, it best fits the general 'Regulatory Filings' (RNS) category as a significant, non-standard regulatory update, or potentially 'LTR' if viewed as a legal/regulatory clearance. Given the context of obtaining certification which is a positive regulatory clearance, RNS is the most appropriate general regulatory announcement fallback.
2025-02-24 English
Uzyskanie certyfikatu CE MDR na bazie komparatora dla urządzenia PacePress
Regulatory Filings Classification · 95% confidence The document text announces the successful completion of the CE MDR comparison certification process for a medical device ("PacePress Fast") and discusses the strategic implications of this achievement for the company's financial performance and market access. This is a specific operational/regulatory achievement announcement that does not fit the definitions for standard financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (DIV, DVA). It is a general regulatory/operational update. Since it is not a standard financial report, nor a director dealing, nor a capital change, the most appropriate general category for a significant regulatory/operational milestone announcement that doesn't fit elsewhere is the general Regulatory Filings category (RNS). The document length is very short (883 chars), suggesting it is an announcement rather than a comprehensive report.
2025-02-24 English
Uzyskanie certyfikatu CE MDR na bazie komparatora dla urządzenia PacePress - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is very short (838 characters) and announces that the Management Board of MEDINICE S.A. received notification from TÜV Nord Polska regarding the positive completion of the CE MDR certification process for the PacePress medical device. This is a specific, material event announcement concerning regulatory approval/product status, which is not explicitly covered by the primary definitions like 10-K, ER, or IR. It is not a general earnings release, dividend notice, or management change. Since it is a specific regulatory/product milestone announcement that doesn't fit the other specific categories (like LTR for legal proceedings or CAP for financing), the most appropriate general category for a significant, non-standard regulatory update is the fallback category, Regulatory Filings (RNS).
2025-02-24 Polish
Uzyskanie certyfikatu CE MDR na bazie komparatora dla urządzenia PacePress
Regulatory Filings Classification · 95% confidence The document is a short announcement from the Management Board (Zarząd) of MEDINICE S.A. regarding receiving CE MDR certification for a medical device component (PacePress Fast) from TÜV Nord Polska. This certification is described as a significant milestone that will positively impact financial results and facilitate regulatory submissions in non-EU countries. Since this is a specific, material announcement concerning regulatory/product status that doesn't fit neatly into standard financial reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, MANG), it falls best under the general 'Regulatory Filings' category, which serves as a fallback for miscellaneous regulatory announcements not covered by other specific codes. Given the short length and the nature of the announcement (a specific regulatory achievement), RNS is the most appropriate general regulatory category.
2025-02-24 Polish
Życiorys P.S.
Board/Management Information Classification · 95% confidence The document text provides detailed biographical and professional information about an individual named Paweł Sobkiewicz, including his current position ('Członek Rady Nadzorczej' - Member of the Supervisory Board), extensive work history, qualifications, and involvement in other companies. This structure—detailing the background, qualifications, and potential conflicts/history of a director or senior manager—is characteristic of disclosures required for board members or management, often found in proxy statements or governance reports. Reviewing the definitions: - It is not a full Annual Report (10-K) or Interim Report (IR). - It is not an Earnings Release (ER) or Call Transcript (CT). - It specifically details the background of a board member, which aligns closely with the scope of Board/Management Information (MANG) or Governance Information (CGR). - Since it focuses heavily on the qualifications and history of a specific member of the supervisory body, it strongly suggests a document related to board composition or director suitability. - The closest fit among the options is 'Board/Management Information' (MANG), which covers 'Announcement of changes in the company's board of directors or senior management,' or 'Governance Information' (CGR), which covers 'Report detailing the company's internal rules, board structure, and governance practices.' Given the focus on an individual's profile, MANG is slightly more specific if this is part of an announcement of appointment/re-election, but CGR covers the general disclosure of board member profiles. In many regulatory contexts, these individual director disclosures are filed alongside proxy materials (DEF 14A) or as part of governance disclosures. Since the text is a detailed profile of a current board member's qualifications and history, it fits best under Board/Management Information (MANG) or potentially Governance Information (CGR). Given the explicit listing of roles and history, MANG is selected as the primary category for director/management profiles.
2025-02-12 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.